<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>4OTI</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>PLoS ONE</Publication><Title>Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes</Title><Author>Chamberlain, Philip</Author><Author>Delker, Silvia</Author><Author>Pagarigan, Barbra</Author><Author>Mahmoudi, Afshin</Author><Author>Jackson, Pilgrim</Author><Author>Abbasian, Mahan</Author><Author>Muir, Jeff</Author><Author>Raheja, Neil</Author><Author>Cathers, Brian</Author><Author>Roujeinikova, Anna</Author><Publisher>PLoS</Publisher><PublicationYear>2014</PublicationYear><DOI>10.1371/journal.pone.0103638</DOI><Volume>9</Volume><Issue>8</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Serine/threonine-protein kinase N1</ChemicalName><MacroMoleculeClass>TRANSFERASE/TRANSFERASE INHIBITOR</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>38653.88</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>ALS BEAMLINE 5.0.2 ADSC QUANTUM 315r</Equipment><Description>Resolution: 1.93</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Thermal><MeasurementMethod>VAPOR DIFFUSION</MeasurementMethod></Thermal><Biological><Sequence>GSMLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC</Sequence><SpaceGroup>P 21 21 21</SpaceGroup><pH>8.5</pH></Biological></PROPERTIES></PolymerNanocomposite>